NEW YORK ( Karvy) - Here are five pharmaceutical stocks under $2 with the potential for handsome returns based on company developments, a strong sector growth outlook for 2011, and analysts' ratings.The pharmaceutical sector outlook for 2011 remains strong with support from emerging and recovering economies, according to analysts at IMS Health. Growth levels globally are likely to range between 5% to 7% with industry revenue estimated to touch a maximum of $890 billion. Although products with more than $30 billion of sales are likely to go off-patent in major markets in 2011, the full impact of the loss won't be experienced until 2012.
5 Pharma Stocks Trading for Under $2
Check Out Our Best Services for Investors
Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Every recommendation goes through 3 layers of intense scrutinyquantitative, fundamental and technical analysisto maximize profit potential and minimize risk.
Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.